BioCentury
ARTICLE | Clinical News

Prednisporin: Phase II data

May 11, 2009 7:00 AM UTC

Data from a double-blind, U.S. Phase II trial in 150 patients showed that Prednisporin (0.1% prednisolone/0.01% cyclosporine A) met the primary endpoint of non-inferiority to Pred Forte 1% prednisolon...